RxDoctor Payments Data

Nicole Burton, APRN

Nurse Practitioner · Omaha, NENPI 1669921342

Payments from drug & device makers

$1,285in general payments, 2019–2025

Across 95 payments — averaging $13.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$367
  • Biohaven Pharmaceutical Holding Company Ltd.$136
  • Collegium Pharmaceutical, Inc.$131
  • Scilex Pharmaceuticals Inc.$126
  • GRT US Holding, Inc.$115
  • Biodelivery Sciences International, Inc.$113
  • plus $295 from 10 others

What the payments were for

  • Food & beverage$1,285100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,285 in reported general payments places this provider in the 75th percentile of 924 nurse practitioner providers in Nebraska.

See all nurse practitioner providers in Nebraska

Medicare billing

Part B allowed, 2024
$25,852
Medicare patients
51
Services billed
407

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban22$30,888
JardianceEmpagliflozin29$29,867
MounjaroTirzepatide15$15,710
TrulicityDulaglutide16$15,375
OzempicSemaglutide13$14,794
ShingrixVaricella-Zoster Ge/As01b/Pf14$3,137
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen33$1,299
Varenicline Tartrate12$1,212
Gabapentin46$926
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen20$835
Albuterol Sulfate HfaAlbuterol Sulfate31$780
Tramadol Hcl31$506
Quetiapine Fumarate17$444
Omeprazole32$436
Oxycodone Hcl22$223

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$26$31,08531 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 924 nurse practitioner providers in Nebraska.

Other nurse practitioner in Omaha

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →